Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Chemical Biology & Drug Design|February 12, 2009
CREDO: a protein-ligand interaction database for drug discoveryAdrian Schreyer, Tom Blundell
Journal of Cheminformatics|November 8, 2012
USRCAT: real-time ultrafast shape recognition with pharmacophoric constraintsAdrian M Schreyer, Tom Blundell
Journal of Chemical Information and Modeling|February 18, 2014
Does a more precise chemical description of protein-ligand complexes lead to more accurate prediction of binding affinity?Pedro J Ballester, Adrian Schreyer, Tom L Blundell
Journal of Computer-Aided Molecular Design|April 6, 2010
Annular tautomerism: experimental observations and quantum mechanics calculationsAurora J Cruz-Cabeza, Adrian Schreyer, William R Pitt
Chemical Biology & Drug Design|June 13, 2009
On the origins of enzyme inhibitor selectivity and promiscuity: a case study of protein kinase binding to staurosporineDuangrudee Tanramluk, Adrian Schreyer, William R Pitt, et al.
International Journal of Biological Macromolecules|September 29, 2025
Crystal structure of dihydrodipicolinate synthase from Mycobacterium tuberculosis in complex with pyruvate and insights into allosteric regulationLuis Victor Santana Rosa, Beata Blaszczyk, Tom Blundell, et al.
Plos One|December 15, 2012
What can we learn from the evolution of protein-ligand interactions to aid the design of new therapeutics?Alicia P Higueruelo, Adrian Schreyer, G Richard J Bickerton, et al.
Chemical Biology & Drug Design|October 9, 2009
Atomic interactions and profile of small molecules disrupting protein-protein interfaces: the TIMBAL databaseAlícia P Higueruelo, Adrian Schreyer, G Richard J Bickerton, et al.
Cancer Research|June 3, 2009
Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasiaAlex Appert, Chang-Hoon Nam, Natividad Lobato, et al.
Pageof 2